Form 4: Schrodinger CEO Ramy Farid Reports Stock Option Grants
SEC Form 4 Filing
Ramy Farid, CEO of Schrodinger, Inc., reports the acquisition of stock options on March 4, 2024.
Summary
- Ramy Farid, the President and CEO of Schrodinger, Inc., filed a Form 4 on March 5, 2024.
- The filing reports the grant of two stock option awards on March 4, 2024.
- The first option is for 126,000 shares with an exercise price of $25.24.
- The second option is for 87,271 shares with an exercise price of $27.76, which is 110% of the closing price on the grant date.
- Both options vest 25% on March 4, 2025, and the remainder in equal monthly installments through March 4, 2028.
- The options expire on March 4, 2034.
Sentiment
Score: 7
Explanation: The document reflects a standard executive compensation practice, which is generally viewed neutrally to positively as it aligns management with shareholder interests. The vesting schedule promotes long-term commitment.
Positives
- The granting of stock options to the CEO aligns his interests with those of the shareholders.
- The vesting schedule encourages long-term commitment from the CEO.
Future Outlook
The document does not contain any specific forward-looking statements or guidance.
Industry Context
Stock option grants are a common form of executive compensation in the technology and pharmaceutical industries, used to incentivize performance and align management interests with shareholder value.
Comparison to Industry Standards
- Stock option grants are a standard component of executive compensation packages in the biotech and software industries.
- Companies like Moderna, BioNTech, and similar software firms often use stock options to attract and retain top talent.
- The vesting schedule of 25% after one year followed by monthly installments is a typical vesting structure.
Stakeholder Impact
- Shareholders may view the stock option grants as a positive incentive for the CEO to drive long-term value.
- Employees may see the grants as a sign of confidence in the company's future.
Key Dates
| Date | Description |
|---|---|
| 03/04/2024 | Date of stock option grants. |
| 03/04/2025 | First vesting date for both stock option grants (25% of shares). |
| 03/04/2028 | End of monthly vesting period for both stock option grants. |
| 03/04/2034 | Expiration date for both stock option grants. |
| 03/05/2024 | Date Form 4 was filed. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.